Showing papers by "William N. Washburn published in 2017"

TL;DR: H hepatobiliary injury by thienopyrimidinone MCHR1 antagonists was driven through a CYP-mediated bioactivation pathway, suggesting that injury of biliary epithelium may be the first step toward an adaptive proliferative response causing BDH by these compounds.